Attached files

file filename
EX-12.1 - EXHIBIT 12.1 - ENDOLOGIX INC /DE/elgx-ex121_computationofra.htm
EX-32.1 - EXHIBIT 32.1 - ENDOLOGIX INC /DE/elgx-ex321_20171231x10k.htm
EX-31.2 - EXHIBIT 31.2 - ENDOLOGIX INC /DE/elgx-ex312_20171231x10k.htm
EX-31.1 - EXHIBIT 31.1 - ENDOLOGIX INC /DE/elgx-ex311_20171231x10k.htm
EX-23.1 - EXHIBIT 23.1 - ENDOLOGIX INC /DE/elgx-ex231_consentofindepe.htm
EX-21.1 - EXHIBIT 21.1 - ENDOLOGIX INC /DE/elgx-ex211_listofsubsidiar.htm
EX-10.23.2 - EXHIBIT 10.23.2 - ENDOLOGIX INC /DE/secondamendmenttolease.htm
EX-10.23.1 - EXHIBIT 10.23.1 - ENDOLOGIX INC /DE/consentassignmentfirstamen.htm
EX-10.23 - EXHIBIT 10.23 - ENDOLOGIX INC /DE/leaseagreement.htm
EX-10.9.2 - EXHIBIT 10.9.2 - ENDOLOGIX INC /DE/elgx-ex1092_secondamendmen.htm
EX-10.9.1 - EXHIBIT 10.9.1 - ENDOLOGIX INC /DE/elgx-ex1091xseparationandc.htm
10-K - 10-K - ENDOLOGIX INC /DE/elgx-20171231x10k.htm


 
Exhibit 32.2
CERTIFICATION
In connection with the Annual Report of Endologix, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Vaseem Mahboob, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ VASEEM MAHBOOB
Vaseem Mahboob
Chief Financial Officer

This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.
Date: March 13, 2018